Total Payments
$2,411
2023 Payments
$30.46
Companies
20
Transactions
204
Medicare Patients
8,098
Medicare Billing
$871,793
Payment Breakdown by Category
Food & Beverage$2,393 (99.2%)
Education$18.64 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,393 | 202 | 99.2% |
| Education | $18.64 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $506.42 | 55 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $299.34 | 17 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $289.81 | 32 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $207.24 | 14 | $0 (2020) |
| Novo Nordisk Inc | $204.33 | 14 | $0 (2020) |
| Amgen Inc. | $145.80 | 10 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $144.36 | 16 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $109.36 | 9 | $0 (2017) |
| Allergan Inc. | $101.62 | 8 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $89.60 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $30.46 | 1 | Ferring Pharmaceuticals Inc. ($30.46) |
| 2020 | $113.53 | 8 | PFIZER INC. ($25.21) |
| 2019 | $548.96 | 49 | Janssen Pharmaceuticals, Inc ($139.53) |
| 2018 | $823.29 | 69 | AstraZeneca Pharmaceuticals LP ($176.53) |
| 2017 | $895.09 | 77 | PFIZER INC. ($176.71) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/23/2023 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: ORTHOPEDICS | ||||||
| 09/24/2020 | E.R. Squibb & Sons, L.L.C. | ABILIFY (Drug) | Education | Cash or cash equivalent | $12.39 | General |
| Category: Neuroscience | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Diabetes | ||||||
| 02/25/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/17/2020 | PFIZER INC. | CHANTIX (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/23/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, STEGLUJAN | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/21/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/13/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/12/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/03/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Respiratory | ||||||
| 11/18/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/14/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/06/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/15/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/03/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Neuroscience | ||||||
| 10/01/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/24/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,873 | 2,924 | $607,930 | $231,366 |
| 2022 | 21 | 1,960 | 3,010 | $531,222 | $215,750 |
| 2021 | 26 | 2,149 | 3,385 | $541,641 | $234,582 |
| 2020 | 26 | 2,116 | 3,356 | $508,885 | $190,096 |
Total Patients
8,098
Total Services
12,675
Medicare Billing
$871,793
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 469 | 1,266 | $307,638 | $99,437 | 32.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 412 | 412 | $102,176 | $50,351 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 366 | $62,952 | $20,276 | 32.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 42 | 42 | $22,260 | $11,838 | 53.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 126 | 128 | $18,788 | $9,122 | 48.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 48 | 55 | $21,340 | $8,439 | 39.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 121 | $16,577 | $7,383 | 44.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 40 | 52 | $10,608 | $4,570 | 43.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 135 | 137 | $7,938 | $3,890 | 49.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 24 | 24 | $7,632 | $3,772 | 49.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 28 | $7,252 | $2,713 | 37.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $4,770 | $2,353 | 49.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,169 | $1,472 | 35.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 16 | $3,184 | $1,469 | 46.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 41 | 41 | $2,296 | $1,173 | 51.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 26 | $2,756 | $1,058 | 38.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 20 | $2,000 | $781.80 | 39.1% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 11 | 11 | $880.00 | $419.32 | 47.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 51 | 52 | $676.00 | $317.72 | 47.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 28 | $1,036 | $258.96 | 25.0% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 22 | 22 | $594.00 | $161.43 | 27.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 43 | 51 | $408.00 | $112.20 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 461 | 1,221 | $262,378 | $92,590 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 377 | 377 | $86,942 | $46,689 | 53.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 252 | 406 | $59,752 | $21,526 | 36.0% |
About Dr. Michael Dee, MD
Dr. Michael Dee, MD is a Internal Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114911005.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Dee, MD has received a total of $2,411 in payments from pharmaceutical and medical device companies, with $30.46 received in 2023. These payments were reported across 204 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,393).
As a Medicare-enrolled provider, Dee has provided services to 8,098 Medicare beneficiaries, totaling 12,675 services with total Medicare billing of $871,793. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Louisville, KY
- Active Since 09/07/2005
- Last Updated 05/05/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1114911005
Products in Payments
- CHANTIX (Drug) $293.44
- XARELTO (Drug) $279.97
- FARXIGA (Drug) $264.01
- ENTRESTO (Drug) $207.24
- Victoza (Drug) $162.40
- LYRICA (Drug) $105.42
- JANUVIA (Drug) $98.87
- ELIQUIS (Drug) $93.94
- VIAGRA (Drug) $70.66
- Aimovig (Biological) $68.11
- PRALUENT (Drug) $65.86
- Prolia (Biological) $63.14
- BASAGLAR (Drug) $39.56
- BYSTOLIC (Drug) $33.40
- SOLIQUA (Drug) $33.04
- DUZALLO (Drug) $32.49
- EUFLEXXA (Device) $30.46
- JARDIANCE (Drug) $29.68
- Ozempic (Drug) $28.61
- NAMZARIC (Drug) $26.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Louisville
Hisham Alrefai, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Matthew Cave, M.d, M.D
Internal Medicine — Payments: $373,716
Internal Medicine $373,716
Dr. Daniel Stewart, M.d, M.D
Internal Medicine — Payments: $284,815
Internal Medicine $284,815
Dr. Jaspreet Grewal, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $262,625
Internal Medicine $262,625
Mohamed Hegazi, Md, MD
Internal Medicine — Payments: $244,885
Internal Medicine $244,885
Dr. Dawn Caster, M.d, M.D
Internal Medicine — Payments: $158,400
Internal Medicine $158,400